IP Library Assignment 051196/0080
Patent Assignment
Reel/Frame 051196/0080

Second Lien Patent Security Agreement

Recorded: 2019-12-04 Pages: 8
Assignors
CAMBREX CHARLES CITY, INC.
Executed: 2019-12-04
AVISTA PHARMA SOLUTIONS, INC.
Executed: 2019-12-04
Assignee
ROYAL BANK OF CANADA, AS COLLATERAL AGENT
20 KING STREET WEST, 4TH FLOOR, TORONTO, M5H 1C4, CANADA
Covered Properties (32)
Nicotine-Containing, Controlled Release Composition and Method
Patent: 6,586,449 →
Application: 10/166,236 →
Nicotine-Containing, Controlled Release Composition and Method
Patent: 6,828,336 →
Application: 10/429,420 →
Publication: US 2003/0224048
Process for Preparing Anhydrous Aripirazole Type I
Patent: 8,039,621 →
Application: 12/445,771 →
Publication: US 2010/0317857
Method of Making Amphetamine
Patent: 7,705,184 →
Application: 12/466,457 →
Publication: US 2009/0292143
Method of Making Piperidine Derivatives
Patent: 8,299,258 →
Application: 12/612,089 →
Publication: US 2010/0137604
Methods and Compositions for Preparing Lisdexamfetamine and Salts Thereof
Patent: 8,779,191 →
Application: 12/973,453 →
Publication: US 2012/0157706
Methods and Compositions for Preparation of Amphetamine Conjugates and Salts Thereof
Patent: 8,614,346 →
Application: 13/378,176 →
Publication: US 2012/0190880
Preparation of Saturated Ketone Morphinan Compounds by Catalytic Isomerisation
Patent: 9,981,978 →
Application: 14/906,776 →
Publication: US 2016/0168159
Antiparasitic Compounds
Patent: 9,420,793 →
Application: 14/995,547 →
Publication: US 2016/0205936
Antiparasitic Compounds
Patent: 9,643,963 →
Application: 15/036,335 →
Publication: US 2016/0280700
Antiparasitic Compounds
Patent: 9,686,991 →
Application: 15/211,062 →
Publication: US 2016/0324156
Antiparasitic Compounds
Application: 15/477,343 →
Publication: US 2017/0202849
Process for the Formation of Hydrocodone Bitatrate
Patent: 9,981,979 →
Application: 15/523,054 →
Publication: US 2017/0327511
Antiparasitic Compounds
Patent: 9,883,674 →
Application: 15/603,556 →
Publication: US 2017/0258089
New Process for Preparing Hydromorphone and Derivatives Thereof
Application: 15/747,980 →
Publication: US 2018/0354961
Antiparasitic Compounds
Application: 15/849,834 →
Publication: US 2018/0116223
A COMPOUND 1-[2-[4-(2-ETHYL-6,8-DIMETHYLIMIDAZO[1,2-a]PYRAZIN-3-YL)PHENYL]ETHYL]-3-(p-TOLYLSULFONYL)UREA AS A PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST
Application: 16/100,315 →
Antiparasitic Compounds
Application: 16/123,251 →
Publication: US 2019/0000085
Single Enantiomer Antiparasitic Compounds
Application: 16/192,103 →
Publication: US 2019/0152983
Substituted Ureas as Prostaglandin EP4 Receptor Antagonists
Application: 16/263,518 →
Publication: US 2019/0382404
Synthetic Process and Intermediates
Application: 16/302,944 →
Publication: US 2019/0284199
Antiparasitic Compounds
Application: 16/315,778 →
Publication: US 2020/0181134
Antiparasitic Compounds
Application: 16/420,627 →
Publication: US 2019/0274305
Antiparasitic Compounds
Application: 62/160,188 →
Synthetic Process and Novel Intermediates
Application: 62/339,136 →
Antiparasitic Compounds
Application: 62/359,719 →
Synthetic Process and Novel Intermediates
Application: 62/491,337 →
Single Enantiomer Antiparasitic Compounds
Application: 62/587,132 →
Chemical Compounds
Application: 62/686,299 →
Chemical Compounds
Application: 62/755,679 →
Synthetic Process and Novel Intermediates
Application: 62/798,735 →
Chemical Compounds
Application: 62/798,738 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Jul 20, 2006
From: SALSBURY CHEMICALS, INC
To: CAMBREX CHARLES CITY, INC
Reel/Frame 017957/0905 →
Assignment of Assignor's Interest Apr 19, 2011
From: BAUER, MICHAEL J.; CALLEN, GARY RICHARD; HUMPHREY, JUDI CHRISTINE; JOHNSON, TODD JEFFREY
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 026148/0179 →
Assignment of Assignor's Interest Apr 12, 2016
From: TRACEY, MICHAEL; HOLMBERG, PÄR
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 038249/0545 →
Assignment of Assignor's Interest Apr 15, 2016
From: SPEAKE, JASON D.; PERALES, JOE B.; FAN, WEIMING; ROLLAND, SOLENE CLARISSE
To: AVISTA PHARMA SOLUTIONS
Reel/Frame 038295/0329 →
Assignment of Assignor's Interest Nov 8, 2016
From: SPEAKE, JASON D; PERALES, JOE B; FAN, WEIMING; ROLLAND, SOLENE CLARISSE
To: AVISTA PHARMA SOLUTIONS
Reel/Frame 040254/0363 →
Assignment of Assignor's Interest Dec 9, 2016
From: MATUTE, BELÉN LINDBERG MARTIN; GÓMEZ, ANTONIO BERMEJO; BÄCKVALL, JAN-ERLING
To: STOCKHOLMS UNIVERSITET HOLDING AB OF STOCKHOLM UNIVERSITY
Reel/Frame 040699/0975 →
Assignment of Assignor's Interest Dec 12, 2016
From: STOCKHOLMS UNIVERSITET HOLDING AB OF STOCKHOLM UNIVERSITY
To: CAMBREX KARLSKOGA AB
Reel/Frame 040708/0988 →
Assignment of Assignor's Interest Dec 13, 2016
From: CAMBREX KARLSKOGA AB
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 040723/0170 →
Assignment of Assignor's Interest Dec 14, 2016
From: MOORE, JOSEPH A; BECK, BRENT C
To: SCYNEXIS, INC.
Reel/Frame 040933/0601 →
Change of Name Dec 14, 2016
From: ACCURATUS LAB SERVICES, INC.
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 040933/0659 →
Assignment of Assignor's Interest Dec 14, 2016
From: LIU, HAO; SLIGAR, JESSICA M; SPEAKE, JASON D
To: SCYNEXIS, INC.
Reel/Frame 040730/0599 →
Assignment of Assignor's Interest Dec 14, 2016
From: SCYNEXIS, INC.
To: ACCURATUS LAB SERVICES, INC.
Reel/Frame 040730/0622 →
Assignment of Assignor's Interest Jan 25, 2017
From: SPEAKE, JASON D; PERALES, JOE B; FAN, WEIMING; ROLLAND, SOLENE CLARISSE
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 041078/0575 →
Assignment of Assignor's Interest May 26, 2017
From: TRACEY, MICHAEL ROBERT; DONG, ZHIMING ERIC
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 042515/0640 →
Assignment of Assignor's Interest Apr 12, 2018
From: HOLMBERG, PÄR; TRACEY, MICHAEL ROBERT; DONG, ZHIMING ERIC
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 045521/0588 →
Assignment of Assignor's Interest Oct 2, 2018
From: SPEAKE, JASON D.
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 047031/0830 →
Security Interest Jan 3, 2019
From: CAMBREX CHARLES CITY, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 047895/0053 →
Security Interest Feb 1, 2019
From: AVISTA PHARMA SOLUTIONS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 048218/0762 →
First Lien Patent Security Agreement Dec 4, 2019
From: AVISTA PHARMA SOLUTIONS, INC.; CAMBREX CHARLES CITY, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051283/0877 →
Notice of Release of Security Interest in Patents Dec 4, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 051283/0903 →
Notice of Release of Security Interest in Patents Dec 4, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 051196/0092 →
Release of Second Lien Security Interest in Patents Dec 7, 2020
From: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 054630/0307 →
Security Interest Mar 6, 2025
From: AVISTA PHARMA SOLUTIONS, INC.
To: ARES AGENT SERVICES, L.P., AS COLLATERAL AGENT
Reel/Frame 070421/0835 →
Release of First Lien Security Interest in Patents Mar 6, 2025
From: ROYAL BANK OF CANADA
To: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.; SNAPDRAGON CHEMISTRY, INC.
Reel/Frame 070438/0333 →
Security Interest Mar 6, 2025
From: CAMBREX CHARLES CITY, INC.
To: ARES AGENT SERVICES, L.P., AS COLLATERAL AGENT
Reel/Frame 070421/0947 →